Goldman Sachs’s VIROPHARMA INC VPHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-10,600
Closed -$528K 7129
2013
Q4
$528K Sell
10,600
-50,400
-83% -$2.25M ﹤0.01% 5256
2013
Q3
$2.4M Buy
61,000
+50,800
+498% +$1.66M ﹤0.01% 3744
2013
Q2
$292K Buy
+10,200
New +$269K ﹤0.01% 5339

Goldman Sachs's VPHM Position: Q1 2014 in Review

Goldman Sachs sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 1,051,896 shares — an estimated $52.4M sold.

Goldman Sachs first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $64.7M in Q3 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

  • Goldman Sachs reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
  • Goldman Sachs sold 1,051,896 VIROPHARMA INC shares in Q1 2014, an estimated $52.4M.
  • Goldman Sachs first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
  • Goldman Sachs's VIROPHARMA INC position peaked at $64.7M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on Goldman Sachs's 13F filing for Q1 2014, filed 15 May 2014.